Clearside Biomedical Inc (CLSD)

NASDAQ
6.350
-0.420(-6.20%)
After Hours
6.450
+0.100(+1.575%)
- Real-time Data
  • Volume:
    385,301
  • Bid/Ask:
    6.450/6.920
  • Day's Range:
    6.277 - 6.590

CLSD Overview

Prev. Close
6.77
Day's Range
6.277-6.59
Revenue
4.25M
Open
6.502
52 wk Range
1.25-7.73
EPS
-0.43
Volume
385,301
Market Cap
377.7M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,038,283
P/E Ratio
-
Beta
1.75
1-Year Change
267.05%
Shares Outstanding
59,479,568
Next Earnings Date
Nov 10, 2021
What is your sentiment on Clearside Biomedical Inc?
or
Market is currently closed. Voting is open during market hours.

Clearside Biomedical Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralStrong Buy
Technical IndicatorsStrong BuyStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellSellStrong Buy

Clearside Biomedical Inc Company Profile

Clearside Biomedical Inc Company Profile

Employees
33

Clearside Biomedical, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Its proprietary suprachoroidal space (SCS) microinjector targeting SCS offers access to the macula, retina and choroid where sight-threatening disease often occurs. The SCS injection platform is an inherently flexible, in-office, non-surgical procedure intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations. The Company’s suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye through SCS. The Company’s lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection.

Read More
  • all in guys,this stock is good
    0
    • Sure all meme stocks are "good" until they are NOT lol
      0
  • all in guys
    0
    • this is the moment to buy !!!
      0
      • price target--> 18$
        0
        • till when?
          0
      • My targets are 12 and 25 in the long run. Bullish on this one
        0
        • think It’s time to buy I bought at 1.70 There are good prospective for ocular drugs
          0
          • you look this equity in fundamental basis or only just in technical basis. please advise me if you can .
            0
        • Ok Folks,I believe Clearside Biomedical is about to spring to $15 or more very soon. CLSD is on a build up and getting ready to spring like a wind up spring. Please keep your eyes on it. I can't hardly wait for the bounce.
          2
          • Hello Mr. Frank, do you have any other advise opinion in which ticker to have a look for short purchase and short sell . best regards., Jack.
            0
          • so what happened bro? looks like it's barely taking off now.
            0
        • darn I bought bunch of call options nooooop
          0
          • its finished
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.